Biotech & Pharma Investor Conference September 24-25 Agenda
WEDNESDAY, SEPTEMBER 24, 2025
All Times are PDT Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Dr. Ira Mellman, President of Research, Parker Center for Cancer Immunotherapy | Former Vice President of Cancer Immunology, Genentech. Topic: Cancer Immunotherapy
9:40am // Corporate Presentation - CNS Pharmaceuticals (CNSP)
9:55am // Corporate Presentation - Senti Bio (SNTI)
10:10am // Corporate Presentation - Avanti Biosciences
10:25am // Corporate Presentation - Applied Cognition
10:40am // Corporate Presentation - OncoPrecision
10:55am // Corporate Presentation - Alphyn Biologics
11:10am // Corporate Presentation - Pacylex Pharmaceuticals
11:25am // Corporate Presentation - CIAN
11:40am // Corporate Presentation - Zena Therapeutics
11:55am // Corporate Presentation - ThinkBio.Ai
12:10pm // Corporate Presentation - AIT-QuantaPro
12:25pm // Corporate Presentation - Object Pharma
12:40pm // LUNCH BREAK
12:55pm // INVESTOR PANEL DISCUSSION. Moderator: Dr. Preetha Ram, Managing Partner, Pier 70 Ventures. Panelists: Phil DiGiacomo, Vice President, Venrock; Lior Teitelbaum, Principal, Venture Investments with J&J (JJDC); Michel Azoulay, Chief Medical Officer, Institute for Follicular Lymphoma Innovation; Edny Inui, Partner, Palo Santo
1:35pm // NETWORKING BREAK
1:50pm // Corporate Presentation - ReEngage Therapeutics
2:05pm // Corporate Presentation - Drusolv Therapeutics
2:20pm // Corporate Presentation - Rakuten Medical
2:35pm // Corporate Presentation - Elastrin Therapeutics
2:50pm // Corporate Presentation - Geneos Therapeutics
3:05pm // Corporate Presentation - Nalu Bio
3:20pm // Corporate Presentation - GenBio AI
3:35pm // NETWORKING BREAK
3:50pm // Corporate Presentation - Ab Studio
4:05pm // Corporate Presentation - Nexture Bio
4:20pm // Corporate Presentation - Greenmark Biomedical
4:35pm // Corporate Presentation - Synlico
4:50pm // Corporate Presentation - Esphera SynBio
5:05pm // Corporate Presentation - TaiMed Biologics
5:20pm // Corporate Presentation - Qureator
5:35pm // SPEAKER - Lila Hope, Partner, Cooley. Topic: China Cross-Border Deals
6:05pm // CLOSING REMARKS
6:15pm // RECEPTION
THURSDAY, SEPTEMBER 25, 2025
All Times are PDT Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE SPEAKER - Dr. Dean Felsher, Director of Translational Research and Applied Medicine| Professor Medicine-Oncology and Pathology, Stanford Medical School. Topic: Targeting the MYC Oncogene Circuit to Reverse Cancer
9:40am // Corporate Presentation - Sonnet BioTherapeutics (SONN)
9:55am // Corporate Presentation - JangoBio
10:10am // Corporate Presentation - Synfini
10:25am // Corporate Presentation - 7 Hills Pharma
10:40am // Corporate Presentation - Circurna
10:55am // Corporate Presentation - Cache DNA
11:10am // Corporate Presentation - Sustained Therapeutics
11:25am // Corporate Presentation - FluGen
11:40am // Corporate Presentation - KeifeRx
11:55am // Corporate Presentation - AIXMED
12:10pm // Corporate Presentation - Cenna Biosciences
12:25pm // Corporate Presentation - Adjuvia Therapeutics
12:40pm // LUNCH BREAK
12:55pm // AI AND THERAPEUTICS PANEL. Moderator: Lauren Creel, Partner, Cooley. Panelists: Dr. Abe Heifets, Founder, Atomwise; Dr. Hanadie Yousef, CEO, Juvena Therapeutics; Qing Zhang, Partner, LDV Partners; Dr. Chris Walters, Director of Investments and Business Development, Formation Bio; Dede Willis, CEO and Co-Founder, Orbit Genomics
1:35pm // SPEAKER - Josh Seidenfeld, Partner, Cooley. Topic: The State of Biotech: Fundraising Trends and Global Transaction Drivers
1:55pm // NETWORKING BREAK
2:10pm // Corporate Presentation - Orbit Genomics
2:25pm // Corporate Presentation - DIMERx
2:40pm // Corporate Presentation - Leapfrog Bio
2:55pm // Corporate Presentation - Bifront Biosystems
3:10pm // Corporate Presentation - DuoBio
3:25pm // Corporate Presentation - ImTol
3:40pm // Corporate Presentation - Sarcomatrix Therapeutics
3:55pm // Corporate Presentation - SciTech Development
4:10pm // SPEAKERS - Steven Ferguson, Special Advisor, NIH Office of Technology Transfer; Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU). Topic: NIH as Your Strategic Partner: Beyond Funding to Market Success
4:35PM // SPEAKER - Dr. Chris Apfel, Director Life Sciences Bay Area, Keiretsu Forum Topic: How to Use Functional Precision Oncology to Increase Clinical Trial Success Rates
5:00PM // SPEAKER - David Choi, Executive Director of Healthcare Investment Banking, J.P. Morgan. Topic: The Current Biotech Market Funding Conditions
5:30pm // CLOSING REMARKS
5:40pm // RECEPTION